These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2751654)

  • 41. Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
    Sumi T; Yoshida H; Hyun Y; Yasui T; Matsumoto Y; Hattori K; Sugimura K; Kawashima H; Nakatani T; Ishiko O
    Oncol Rep; 2003; 10(2):345-9. PubMed ID: 12579270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of alpha-defensin is associated with bladder cancer invasiveness.
    Holterman DA; Diaz JI; Blackmore PF; Davis JW; Schellhammer PF; Corica A; Semmes OJ; Vlahou A
    Urol Oncol; 2006; 24(2):97-108. PubMed ID: 16520271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.
    Davies B; Waxman J; Wasan H; Abel P; Williams G; Krausz T; Neal D; Thomas D; Hanby A; Balkwill F
    Cancer Res; 1993 Nov; 53(22):5365-9. PubMed ID: 8221672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition by elastase inhibitors of the formyl Met Leu Phe-induced chemotaxis of rat polymorphonuclear leukocytes.
    Hornebeck W; Soleilhac JM; Tixier JM; Moczar E; Robert L
    Cell Biochem Funct; 1987 Apr; 5(2):113-22. PubMed ID: 3495371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased REG1α expression suppresses growth, invasion and angiogenesis of bladder cancer.
    Geng J; Fan J; Wang Q; Zhang XP; Kang L; Li QY; Xu YF; Peng B; Zheng JH; Yao XD
    Eur J Surg Oncol; 2017 Apr; 43(4):837-846. PubMed ID: 28209239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s).
    Redwood SM; Liu BC; Weiss RE; Hodge DE; Droller MJ
    Cancer; 1992 Mar; 69(5):1212-9. PubMed ID: 1739920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor.
    Herbert JM; Frehel D; Rosso MP; Seban E; Castet C; Pepin O; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1992 Feb; 260(2):809-16. PubMed ID: 1738126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Elastase from the hepatopancreas of the king crab].
    Sakharov IIu; Dzhunkovkaia AV
    Biokhimiia; 1993 Aug; 58(9):1445-53. PubMed ID: 8218568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Superficially invasive transitional cell carcinoma of the bladder associated with distant cutaneous metastases.
    Swick BL; Gordon JR
    J Cutan Pathol; 2010 Dec; 37(12):1245-50. PubMed ID: 19919656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Morphologic and histochemical study of several tumors of the bladder].
    Bialik VL; Romanenko AM
    Arkh Patol; 1972; 34(5):22-8. PubMed ID: 5043690
    [No Abstract]   [Full Text] [Related]  

  • 51. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.
    Neal DE; Marsh C; Bennett MK; Abel PD; Hall RR; Sainsbury JR; Harris AL
    Lancet; 1985 Feb; 1(8425):366-8. PubMed ID: 2857420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynolds LM
    J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor.
    Thompson K; Rabinovitch M
    J Cell Physiol; 1996 Mar; 166(3):495-505. PubMed ID: 8600153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of α‑ and β‑Klotho in urothelial carcinoma of the bladder.
    Hori S; Miyake M; Onishi S; Tatsumi Y; Morizawa Y; Nakai Y; Anai S; Tanaka N; Fujimoto K
    Oncol Rep; 2016 Oct; 36(4):2117-25. PubMed ID: 27573985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elastolytic activity of MAP1, a protease from Myxococcus xanthus.
    Dumont L; Verneuil B; Julien R; Wallach J
    Biochem Mol Biol Int; 1994 Jun; 33(3):535-42. PubMed ID: 7951071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The degradation of human lung elastin by neutrophil proteinases.
    Reilly CF; Travis J
    Biochim Biophys Acta; 1980 Jan; 621(1):147-57. PubMed ID: 6153274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human lysosomal elastase. Catalytic and immunological properties.
    Starkey PM; Barrett AJ
    Biochem J; 1976 May; 155(2):265-71. PubMed ID: 938478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elastase secretion by stimulated macrophages. Characterization and regulation.
    Werb Z; Gordon S
    J Exp Med; 1975 Aug; 142(2):361-77. PubMed ID: 167096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex.
    Monami G; Gonzalez EM; Hellman M; Gomella LG; Baffa R; Iozzo RV; Morrione A
    Cancer Res; 2006 Jul; 66(14):7103-10. PubMed ID: 16849556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of human leukocyte elastase with soluble and insoluble protein substrates. A practical kinetic approach.
    Baici A
    Biochim Biophys Acta; 1990 Sep; 1040(3):355-64. PubMed ID: 2223841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.